OUTSTANDING ACADEMIC CAREER OPPORTUNITY
SENIOR RESEARCH SCIENTIST, MELANOMA
CUTANEOUS ONCOLOGY PROGRAM CEDARS-SINAI CANCER
Cedars-Sinai Cancer is conducting a national search for a senior melanoma research scientist to coordinate and direct basic and translational research of the Cutaneous Oncology Program. The incumbent will hold a Melanoma Endowed Chair. This is an exciting and transformational time for the cancer enterprise at Cedars-Sinai, #12 on US News & World Report cancer ranking, with its plans and aspirational goals to be an internationally recognized cancer center. Cedars-Sinai Cancer sees over 4800 new cases of cancer per year and is part of Cedars-Sinai Health System, a rapidly expanding vertically integrated health enterprise with practices located in Southern California, including Tower Hematology-Oncology, The Angeles Clinic and Research Institute, Cedars-Sinai Valley Oncology Medical Group, the Marina Del Rey Hospital, Hunt Cancer Institute at Torrance Memorial, and Cedars-Sinai Medical Center. Cedars-Sinai is one of the nation’s premier healthcare institutions and ranks #8 on US News & World Report Best Hospital in 2019.
The Cutaneous Oncology Program at Cedars-Sinai Cancer is internationally recognized with expertise in drug development, patient care, and translational research. Its focus lies in the field of immunotherapy including checkpoint inhibitors, bispecific antibodies, and adoptive cell therapy. Led by Drs. Mark Faries and Omid Hamid, the program has been instrumental to the development and FDA approval of checkpoint inhibitors over the last decade (nivolumab, ipilimumab, durvalumab, pembrolizumab, avelumab, atezolizumab) with a greater focus on next generation checkpoint targets, bispecifics, cell therapy, CAR-T cell and other cellular therapy products. Our search will identify an accomplished, federally-funded research scientist with a demonstrated successful research program in melanoma. The candidate will work with medical, radiation and surgical oncologists, endocrinologists, radiologists, otolaryngologists, pathologists, neurologists, and population and basic scientists to establish a first-rate melanoma research program across Cedars-Sinai Cancer by leveraging the translational opportunities afforded by a busy clinical research program and established, clinically-annotated biobank protocols.
RESEARCH SCIENTIST, MELANOMA Position Summary: The objective of the position is to develop a comprehensive translational research (bench to bedside) program to study the pathophysiology, prevention, detection and treatment of primary and metastatic melanomas. Qualified individuals will have a MD and/or PhD with experience in a basic science and translational research laboratory and evidence of academic productivity. Such an individual will work closely with the medical directors of the Cutaneous Oncology Program to develop groundbreaking discoveries to guide patient selection and therapies in the field of cancer immunology including the development of blood and tissue-based biomarkers. This position would leverage an established high-volume internationally recognized multidisciplinary oncology program to develop new knowledge and apply that knowledge to novel paradigm shifting diagnostic, prognostic, predictive and therapeutic clinical protocols.
The candidate will work collaboratively with cancer physicians and investigators across the Cedars-Sinai Health System in the development of research, clinical and educational programs. The candidate must create the scientific culture and environment that promote the submission of research grants by Cutaneous Oncology Program members. The candidate is responsible for identifying, promoting and mentoring young investigators in melanoma research as well as participating with the Director of the Cancer Center in securing philanthropic support for the program. Primary responsibilities will be promoting excellence (clinical, research, education) of the Cutaneous Oncology Program including but not limited to the following:
Research: Engage in peer-reviewed funded research in melanoma, either basic, translational, population, health services areas and/or clinical trials that advances the Cancer Center’s strategic plan. Work to increase research funding from external sponsors including federal, industry and foundation.
Education: Develop and/or contribute to the development of training programs in melanoma related sciences with institutional educational leaders. Identify and promote the mentoring of young investigators in melanoma research. Contribute to the training of clinical and research fellows and laboratory staff in translational, population, and basic research in melanoma.
Clinical: If so qualified, provide professional and consultative expertise in melanoma therapy.
Programmatic: Contribute to the development of a comprehensive research program to conduct basic, translational clinical and prevention research in melanoma. Promote success in obtaining external support through NIH, foundations, biotech/pharma and other extramural agencies for research. Advise and foster participation by interested and qualified attending staff physicians and trainees in relevant research areas. Provide mentorship and guidance for researchers in the program as needed.
Collaborate within a team composed of the Cutaneous Oncology Program leaders in Surgical Oncology, Radiation Oncology, Medical Oncology, , Radiology and Pathology. Coordinate with members of the Cutaneous Oncology Program to maintain high quality standards and quality assurance programs. Assist the medical directors of the Cutaneous Oncology Program to organize, implement and direct fiscally responsible research, clinical and educational programs in melanoma. Recruit faculty focused on prevention, translational or clinical melanoma research. Work with the Director of the Cancer Center in securing philanthropic support for the program and marketing the program throughout the loco-regional and national/international communities. Participate in appropriate divisional, departmental and institutional committees and programs.
Required Qualifications: • Five or more years’ experience in melanoma research (basic, translational, prevention or clinical). • MD, PhD or MD/PhD or equivalent from an accredited university. • For MD or MD/PhD, Board Certification in Internal Medicine, Surgery, Hematology/Oncology, Radiation Oncology or Pathology by the corresponding American Board or the equivalent. • National prominence in melanoma research, with outstanding peer-reviewed publications, proven abilities as Principal Investigator and mentor. • Demonstrated ability to obtain and sustain federal funding (NIH, NSF, DOD, etc.) • For MD or MD/PhD or equivalent, ability to obtain an unrestricted California medical license as Physician.
We are among the nation’s leading providers of healthcare services, medical education and medical research, with total annual revenues of $3.7 billion. Cedars-Sinai is one of the largest non-profit academic medical centers in the U.S. with 886 licensed beds, 2,600 physicians, 3,000 nurses and thousands of other healthcare professionals and staff. Clinical programs range from primary care for preventing, diagnosing and treating common conditions to specialized treatments for rare, complex and advanced illnesses.
Interested candidates should send their CVs to Dan Theodorescu MD PhD, Director Cedars-Sinai CANCER c/o email@example.com
Cedars-Sinai encourages and welcomes diversity in the workplace AA/EOE